References
- Marshall NE, Fu R, Guise JM. Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol. Mosby Inc. 2011;205(3):262.e1–262.e8.
- Iacovelli A, Liberati M, Khalil A, et al. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2020;33(3):471–481.
- Stotler B, Padmanabhan A, Devine P, et al. Transfusion requirements in obstetric patients with placenta accreta. Transfusion (Paris). 2011;51(12):2627–2633.
- Shellhaas CS, Gilbert S, Landon MB, et al. The frequency and complication rates of hysterectomy accompanying cesarean delivery. Obstetr Gynecol. 2009;114(2):224–229.
- Allen L, Jauniaux E, Hobson S, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management. Int J Gynecol Obstet. 2018;140(3):281–290.
- Aggarwal R, Suneja A, Vaid NB, et al. Morbidly adherent placenta: a critical review. J Obstet Gynecol India. 2012;62(1):57–61.
- D’Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstetr Gynecol. 2013;42:509–517.
- Einerson BD, Silver RM. Multidisciplinary teams in the management of placenta accreta spectrum disorders. Curr Obstet Gynecol Rep. 2019;8(3):80–85.
- Fitzpatrick K, Sellers S, Spark P, et al. The management and outcomes of placenta accreta, increta, and percreta in the UK : a population‐based descriptive study. BJOG. 2014;121:62–70.
- Bailit JL, Grobman WA, Rice MM, et al. Morbidly adherent placenta treatments and outcomes. Obstetr Gynecol. 2015;125(3):683–689.
- Cahill AG, Beigi R, Heine RP, et al. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219(6):B2–B16.
- Karkhanis P, Ahmed I, Irani S. Placenta accreta spectrum disorders – detection rate and maternal outcomes following implementation of an institutional protocol. J Obstet Gynaecol (Lahore). 2021;42(2):202–208.
- Shamshirsaz AA, Fox KA, Erfani H, et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol. 2017;216:612.e1–612.e5.
- Shamshirsaz AA, Fozx KA, Erfani H, et al. The role of centers of excellence with multidisciplinary teams in the management of abnormal invasive placenta. Clin Obstet Gynecol. 2018;61:841–850.
- Al-Khan A, Gupta V, Illsley NP, et al. Maternal and fetal outcomes in placenta accreta after institution of team-managed care. Reprod Sci. 2014;21(6):761–771.
- Smulian JC, Pascual A-L, Hesham H, et al. Invasive placental disease: the impact of a multi-disciplinary team approach to management. J Matern-Fetal Neonatal Med. 2017;30(12):1423–1427.
- Wright JD, Silver RM, Bonanno C, et al. Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta. J Matern-Fetal Neonatal Med. 2013;26(16):1602–1609.
- US Census. US Census [Internet]. Available from: www.census.gov.
- Ioffe YJM, Burruss S, Yao R, et al. When the balloon goes up, blood transfusion goes down: a pilot study of REBOA in placenta accreta spectrum disorders. Trauma Surg Acute Care Open. 2021;6(1):e000750.
- Buca D, Liberati M, Calì G, et al. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;52(3):304–309.
- Palacios-Jaraquemada JM, D’Antonio F, Buca D, et al. Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome. J Matern-Fetal Neonatal Med. 2020;33(19):3377–3384.
- Calí G, Timor‐Tritsch IE, Forlani F, et al. Value of first‐trimester ultrasound in prediction of third‐trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome. Ultrasound Obstet Gynecol. 2020;55(4):450–459.